CareDx (CDNA)
(Delayed Data from NSDQ)
$22.64 USD
+0.51 (2.30%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $22.66 +0.02 (0.09%) 7:58 PM ET
1-Strong Buy of 5 1
F Value A Growth D Momentum C VGM
Price, Consensus and EPS Surprise
CDNA 22.64 +0.51(2.30%)
Will CDNA be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CDNA based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CDNA
Humana Q3 Earnings Beat on Growing Premiums & Cost Management
Encompass Health Opens 9th Hospital in SC: More in the Pipeline?
CDNA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Select Medical Rises 50.2% YTD: Take Profits or Bet on More Gains?
Teladoc Stock Rises 12% as Jefferies Boosts Price Target on BetterHelp
Community Health's Arm Northwest Urgent Buys 10 Arizona Facilities
Other News for CDNA
CareDx Inc (CDNA) Shares Up 2.91% on Nov 1
Natera And GeneDx: Outperforming Market Powered By Precision Medicines Tailwinds
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
CareDx Inc (CDNA) Shares Down 2.49% on Oct 29
Craig-Hallum Issues a Buy Rating on CareDx (CDNA)